These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1511766)

  • 1. Severe ovarian hyperstimulation: a case report and essentials of prevention and management.
    Scheele F; Hompes PG; Bernardus RE; Schoemaker J
    Eur J Obstet Gynecol Reprod Biol; 1992 Jul; 45(3):187-92. PubMed ID: 1511766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe ovarian hyperstimulation syndrome (OHSS) and icterus.
    Nawroth F; Heinrich J; Bruns U; Wood WG
    Hum Reprod; 1996 Nov; 11(11):2441-2. PubMed ID: 8981129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the oral contraceptive pill on patients undergoing controlled ovarian hyperstimulation.
    Frederick J; DaCosta V; Wynter S; Reid M; Frederick C; McKenzie C
    West Indian Med J; 2004 Jan; 53(1):39-43. PubMed ID: 15114893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coasting may reduce the severity of the ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome.
    Ohata Y; Harada T; Ito M; Yoshida S; Iwabe T; Terakawa N
    Gynecol Obstet Invest; 2000; 50(3):186-8. PubMed ID: 11014952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triggering of ovulation using a gonadotrophin-releasing hormone agonist does not prevent ovarian hyperstimulation syndrome.
    van der Meer S; Gerris J; Joostens M; Tas B
    Hum Reprod; 1993 Oct; 8(10):1628-31. PubMed ID: 8300818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study on follicle stimulation and ovulation induction in polycystic ovary syndrome (PCOS).
    Ito T; Michioka T; Kobayashi M; Narimatsu A; Yamashita S; Matsuzaki H; Kuramoto T; Numa F; Yakabe A
    Horm Res; 1990; 33 Suppl 2():32-4. PubMed ID: 2128879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of buserelin and low-dose human menopausal gonadotropin for in vitro fertilization in women at risk of ovarian hyperstimulation syndrome.
    Wada I; Matson PL; Troup SA; Lieberman BA
    J Assist Reprod Genet; 1995 Apr; 12(4):252-7. PubMed ID: 7580021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
    Gerris J; De Vits A; Joostens M; Van Royen E
    Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of polycystic ovarian disease by inducing ovulation with pulsatile subcutaneous administration of human menopausal gonadotrophin associated with luteinizing hormone-releasing hormone analogue.
    Nakamura Y; Yoshimura Y; Tamaoka Y; Ubukata Y; Yoshida K; Yamada H; Iizuka R; Suzuki M
    Clin Endocrinol (Oxf); 1988 Oct; 29(4):395-402. PubMed ID: 3150824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of ovulation with pulsatile subcutaneous administration of human menopausal gonadotropin in patients with polycystic ovary syndrome.
    Nakamura Y; Yamada H; Yoshida K; Manno T; Ubukata Y; Suzuki M; Yoshimura Y
    Horm Res; 1990; 33 Suppl 2():43-8. PubMed ID: 2128881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laser vaporization of the ovarian surface in polycystic ovary disease results in reduced ovarian hyperstimulation and improved pregnancy rates.
    Fukaya T; Murakami T; Tamura M; Watanabe T; Terada Y; Yajima A
    Am J Obstet Gynecol; 1995 Jul; 173(1):119-25. PubMed ID: 7631668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of polycystic ovary patients undergoing IVF.
    Barri PN; Coroleu B; Martinez F; Traver JM; Veiga A; Calderon G
    J Assist Reprod Genet; 1997 Jan; 14(1):10-2. PubMed ID: 9013302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth patterns of ovarian follicles during induction of ovulation with decreasing doses of human menopausal gonadotropin following presumed selection in polycystic ovary syndrome.
    Schoot DC; Pache TD; Hop WC; de Jong FH; Fauser BC
    Fertil Steril; 1992 May; 57(5):1117-20. PubMed ID: 1572484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of patients with polycystic ovaries undergoing IVF.
    Franks S
    J Assist Reprod Genet; 1997 Jan; 14(1):12-4. PubMed ID: 9013303
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention and management of ovarian hyperstimulation syndrome.
    Nelson SM
    Thromb Res; 2017 Mar; 151 Suppl 1():S61-S64. PubMed ID: 28262238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian hyperstimulation syndrome and deep vein thrombosis.
    Sobande AA; Archibong EI; Albar HM
    Saudi Med J; 2000 Aug; 21(8):783-4. PubMed ID: 11423899
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention and management of ovarian hyperstimulation syndrome.
    Chen CD; Chen SU; Yang YS
    Best Pract Res Clin Obstet Gynaecol; 2012 Dec; 26(6):817-27. PubMed ID: 22647872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemic stroke due to induction of ovulation with clomiphene citrate and menotropins without evidence of ovarian hyperstimulation syndrome.
    Inbar OJ; Levran D; Mashiach S; Dor J
    Fertil Steril; 1994 Nov; 62(5):1075-6. PubMed ID: 7926122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Native gonadotropin-releasing hormone for triggering follicular maturation in polycystic ovary syndrome patients undergoing human menopausal gonadotropin ovulation induction.
    Blumenfeld Z; Lang N; Amit A; Kahana L; Yoffe N
    Fertil Steril; 1994 Sep; 62(3):456-60. PubMed ID: 8062938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of ovulation in polycystic ovarian disease.
    Fleming R
    Prog Clin Biol Res; 1986; 225():401-12. PubMed ID: 3097675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.